Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1996
12/19/1996WO1996040072A2 Composition for sustained release of human growth hormone
12/19/1996WO1996040069A1 System and method for producing drug-loaded microparticles
12/19/1996WO1996040068A1 Methods and system for processing dispersible fine powders
12/19/1996WO1996040064A1 Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications
12/19/1996WO1996040049A1 Peptide/protein suspended formulations
12/19/1996WO1996040048A2 Novel uses for thyroid hormones or thyroid hormone-like compounds
12/19/1996WO1996040041A2 Antibodies to fas antigen capable of inhibiting apoptosis
12/19/1996WO1996040040A2 Thrombin receptor homolog
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996WO1996040033A1 Non-biological patch for hemostasis
12/19/1996WO1996039842A1 Moist bacteriocin disinfectant wipes and methods of using the same
12/19/1996WO1996039841A1 Tumor- or cell-specific herpes simplex virus replication
12/19/1996WO1996039834A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
12/19/1996WO1996039831A1 Prodrugs of pharmaceuticals with improved bioavailability
12/19/1996WO1996039830A1 Pericardial therapeutic and diagnostic agent delivery
12/19/1996WO1996021021A3 A cancer associated gene, testis-associated helicase (tah), protein expressed therefrom and uses thereof
12/19/1996DE19521974A1 Pharmazeutische Zubereitung mit Cyclosporin A A pharmaceutical preparation containing cyclosporin A
12/19/1996DE19521938A1 Use of compsns. contg. cyclic lipo-peptide(s) as anti-mycotic(s)
12/19/1996DE19521829A1 Neue Verwendung von Collagenase New use of collagenase
12/19/1996DE19521314A1 Adhärenzgen aus Helicobacter pylori und davon codiertes Polypeptid Adhärenzgen from Helicobacter pylori and it polypeptide encoded
12/19/1996CA2787069A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2786782A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2704354A1 Expression of lipoproteins
12/19/1996CA2628032A1 Agonist peptide dimers
12/19/1996CA2451973A1 Method of increasing the solubility of tissue factor pathway inhibitor
12/19/1996CA2451970A1 Method to aid refolding of tissue factor pathway inhibitor
12/19/1996CA2451969A1 Method of purifying tissue factor pathway inhibitor
12/19/1996CA2450953A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450804A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450800A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450797A1 Method of solubilizing proteins containing two oppositely-charged domains
12/19/1996CA2450795A1 Method of refolding tissue factor pathway inhibitor
12/19/1996CA2352900A1 Small molecule inhibitors of rotamase enzyme activity
12/19/1996CA2288401A1 Icam-4 materials and methods
12/19/1996CA2228998A1 Prevention and treatment of sepsis
12/19/1996CA2228277A1 Agonist peptide dimers
12/19/1996CA2226546A1 Promotion of homologous dna pairing by reca-derived peptides
12/19/1996CA2224463A1 Ocular therapy in sjogren's syndrome using topically applied androgens or tgf-.beta.
12/19/1996CA2224227A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds
12/19/1996CA2224191A1 Urethane mediated, gst specific molecular release systems
12/19/1996CA2224184A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
12/19/1996CA2224180A1 Ketoheterocyclic inhibitors of factor xa
12/19/1996CA2224174A1 Method for obtaining receptor agonist antibodies
12/19/1996CA2224172A1 Use of gram-positive bacteria to express recombinant proteins
12/19/1996CA2224170A1 Delivery of drugs to the lower gi tract
12/19/1996CA2224160A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
12/19/1996CA2224149A1 Immunogenic peptides of prostate specific antigen
12/19/1996CA2224119A1 Method for treating multiple sclerosis
12/19/1996CA2224115A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996CA2224113A1 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996CA2224110A1 Peptidyl heterocycles useful in the treatment of thrombin related disorders
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996CA2224076A1 Inhibitors of factor xa
12/19/1996CA2224064A1 Methods and system for processing dispersible fine powders
12/19/1996CA2224015A1 Streptococcal heat shock proteins members of the hsp70 family
12/19/1996CA2224012A1 Developmentally-regulated endothelial cell locus-1
12/19/1996CA2223993A1 Method for treating tumors with a toxin
12/19/1996CA2223940A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996CA2223928A1 Cationic lipid:dna complexes for gene targeting
12/19/1996CA2223924A1 Iodine-containing peptides
12/19/1996CA2223923A1 Cationic lipid:dna complexes for gene targeting
12/19/1996CA2223891A1 Treatment of insulin resistance
12/19/1996CA2223889A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
12/19/1996CA2223885A1 Platelet-specific chimeric immunoglobulin and methods of use therefor
12/19/1996CA2223878A1 Inhibitors of phospholipase a2
12/19/1996CA2223834A1 Composition for sustained release of non-aggregated erythropoietin
12/19/1996CA2223832A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996CA2223771A1 Catalytic dna
12/19/1996CA2223737A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
12/19/1996CA2223734A1 Compositions and methods for improving autologous fat grafting
12/19/1996CA2223717A1 Modified steroid hormones for gene therapy and methods for their use
12/19/1996CA2223714A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease
12/19/1996CA2223687A1 Apl immunoreactive peptides, conjugates thereof and methods of treatment for apl antibody-mediated pathologies
12/19/1996CA2223611A1 Appetite regulating compositions
12/19/1996CA2223608A1 Vaccine for porcine reproductive and respiratory syndrome virus
12/19/1996CA2223605A1 Stable formulations of mhc-peptide complexes
12/19/1996CA2223584A1 Crosslinking oligonucleotides
12/19/1996CA2223583A1 Device for releasing aggregation-stabilized, biologically active agent
12/19/1996CA2223549A1 Capped synthetic rna, analogs, and aptamers
12/19/1996CA2223531A1 Reducing gelation of a fatty acid-acylated protein
12/19/1996CA2223501A1 Novel peptide inhibitors of calmodulin
12/19/1996CA2223500A1 Thrombin inhibitors
12/19/1996CA2223495A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
12/19/1996CA2223446A1 Thrombopoietin compositions
12/19/1996CA2223436A1 Composition for sustained release of human growth hormone
12/19/1996CA2223428A1 Novel mu opioid receptor ligands: agonists and antagonists
12/19/1996CA2223303A1 Treatment of t cell mediated autoimmune disorders
12/19/1996CA2223292A1 Single chain analogs of the tgf-.beta. superfamily (morphons)
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2223262A1 Lymphocyte chemoattractant factor and uses thereof
12/19/1996CA2223246A1 Cell line producing analgesic compounds for treating pain
12/19/1996CA2223181A1 Adenosine kinase polynucleotides
12/19/1996CA2223143A1 Peptide fragments of tissue factor and their use for treatment and prevention of clotting disorders
12/19/1996CA2223109A1 Use of antisense oligonucleotides to il-6 receptor mrna to inhibit cellular proliferation
12/19/1996CA2223088A1 Novel carbamate-based cationic lipids
12/19/1996CA2223086A1 Novel serpin derived from human hypothalamus
12/19/1996CA2223077A1 Thrombin receptor homolog
12/19/1996CA2223046A1 Methods for increasing hematopoietic cells
12/19/1996CA2223041A1 Immunological combination compositions and methods
1 ... 2746 2747 2748 2749 2750 2751 2752 2753 2754 2755 2756 2757 2758 2759 2760 2761 2762 2763 2764 2765 2766 ... 3163